Objective Pancreatic beta cells proliferate in response to metabolic requirements during
pregnancy, while failure of this response may cause gestational diabetes. A member of the …

Objectives Reduced increase in serum placental growth factor (PLGF) levels frequently
occurs in patients with pre‐eclampsia (PE) and thus has been used as a predictive factor for …

Reduced placental growth factor (PLGF) during pregnancy is known to be a reason for
developing preeclampsia (PE) and gestational diabetes mellitus (GDM), but the underlying …

Placenta growth factor (PlGF) has been implicated in both physiological and pathological
angiogenesis; however, little is known about what regulates its expression. In this study …

Background/Aim: Reduction in serum placental growth factor (PLGF) frequently co-occurs
with preeclampsia (PE) and gestational diabetes mellitus (GDM). Recently, we reported that …

Aim: To analyze the role of maternal placental growth factor (PlGF) in the prediction of small
for gestational age (SGA) birth weight in pregnancy complicated by type 1 diabetes mellitus …

Objective: Determine the independent association between time-specific placental growth
factor (PIGF)—a marker of placental vasculature—and infant birth weight in offspring of …

Placental growth factor (PlGF) is an angiogenic factor identified in the maternal circulation,
and a key biomarker for the diagnosis and management of placental disorders. Furthermore …

Objective: As only limited and confusing evidence about serum placental growth factor
(PlGF) level in gestational diabetes mellitus (GDM) exist in the known literature, the aim of …

The placenta produces several growth factors, including placenta growth factor (PlGF),
which are essential for placenta growth and fetal growth. Diabetic pregnancy induces the …